Surface Scanning Morphometry of Premature Infants using Photogammetry

Overview

About this study

The objective of this innovative project is to determine variance and rate of change in facial morphometry in neonates, ranging in weight from 400 grams up to babies weighing over 4 kg. If successful, the proposed developments will likely have far reaching consequences in other neonatal care applications such as custom-fit neonatal CPAP masks. 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  1. Male or female gender.
  2. Patients admitted to the Neonatal Intensive Care Unit.
  3. Gestational age range from premature to 18 years old.
  4. Parental/guardian willingness to provide informed consent and for the study protocol.
  5. Patients demonstrating sufficient respiratory stability to be extubated from endotracheal intubation and mechanical ventilation and transitioned to nasal CPAP.

Exclusion Criteria:

  1. Congenital anomalies of the face including but not limited to cleft lip or palate and choanal atresia.
  2. Respiratory instability requiring ongoing endotracheal intubation and mechanical ventilation.
  3. Any preexisting pressure ulcer of the philtrum or nares

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Mark Wylam, M.D.

Closed-enrolling by invitation

What is this? (?)
"Close"
Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.

Contact information:

Mark Wylam M.D.

(507) 266-0707

Wylam.Mark@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20325249

Mayo Clinic Footer